SRIVARU Holding Limited Secures Nasdaq Panel Approval for Continued Listing Amid Compliance Efforts
September 19, 2024 11:54 ET
|
SRIVARU Holding
GRAND CAYMAN, Cayman Islands, Sept. 19, 2024 (GLOBE NEWSWIRE) -- SRIVARU Holding Limited (Nasdaq: SVMH, SVMHW) ("SRIVARU" or the "Company"), a leading innovator in the electric motorcycle market,...
Earlyworks and CAICA DIGITAL Entered into a Business Alliance Agreement to Support the Expansion of Web3 Business
September 19, 2024 10:45 ET
|
EARLYWORKS CO., LTD.
TOKYO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (NASDAQ: ELWS) ("Earlyworks" or the "Company"), a blockchain solution provider headquartered in Taito-ku, Tokyo which develops its...
IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology
September 19, 2024 10:00 ET
|
IMAC Holdings, Inc.
Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader in innovative healthcare solutions, proudly announces the launch of...
Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th
September 19, 2024 10:00 ET
|
Bright Minds Biosciences
Bright Minds Biosciences will host the Key Opinion Leader event with leading experts in epilepsy research and treatment on September 25
First Financial Corporation Declares Quarterly Dividend
September 19, 2024 10:00 ET
|
First Financial Corporation Indiana
TERRE HAUTE, Ind., Sept. 19, 2024 (GLOBE NEWSWIRE) -- The directors of First Financial Corporation (NASDAQ: THFF) have declared a dividend of 45 cents per share payable on October 15, 2024, to...
FibroBiologics Engages Southern Star Research as CRO in Australia
September 19, 2024 09:31 ET
|
Fibrobiologics, Inc.
HOUSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...
Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board
September 19, 2024 09:31 ET
|
Immix Biopharma, Inc.
Dr. Comenzo was the senior author of the landmark Andromeda trial results published in the New England Journal of Medicine in 2021, resulting in the first FDA-approved therapy for AL...
Haoxi Health Technology Limited Announces Pricing of a $12 Million Underwritten Follow-on Public Offering
September 19, 2024 09:25 ET
|
Haoxi Health Technology Limited
BEIJING, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced the...
Update: noco-noco Inc Announces Significant New Financing - Committed Equity Facility Up to $150 million
September 19, 2024 09:17 ET
|
noco-noco Inc.
Singapore, Sept. 19, 2024 (GLOBE NEWSWIRE) -- noco-noco Inc Announces Significant New Financing - Committed Equity Facility Up to $150 million - - Significantly...
Jewett-Cameron Retains Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication Program
September 19, 2024 09:00 ET
|
Jewett-Cameron Trading Company Ltd.
NORTH PLAINS, Ore., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Jewett-Cameron Trading Company Ltd. (“Jewett-Cameron”) (Nasdaq: JCTCF), a company committed to innovative products that enrich outdoor spaces,...